Glucose-induced insulin secretion from hyperglycemic 90% pancreatectomized rats is markedly impaired, possibly because of loss of beta cell differentiation. Association of these changes with beta cell hypertrophy, increased mRNA levels of the transcription factor c-Myc, and their complete normalization by phlorizin treatment suggested a link between chronic hyperglycemia, increased c-Myc expression, and altered beta cell function. In this study, we tested the effect of hyperglycemia on rat pancreatic islet c-Myc expression both in vivo and in vitro. Elevation of plasma glucose for 1-4 days (glucose infusion/clamp) was followed by parallel increases in islet mRNA levels (relative to TATA-binding protein) of c-Myc and two of its target genes, ornithine decarboxylase and lactate dehydrogenase A. Similar changes were observed in vitro upon stimulation of cultured islets or purified beta cells with 20 and 30 mmol.liter(-1) glucose for 18 h. These effects of high glucose were reproduced by... 
proposed to explain this so called "glucose toxicity," including ␤ cell overstimulation, increased oxidative stress, protein glycation, and islet amyloid pancreatic polypeptide deposition. We have recently shown that 2-4 weeks after a 90% pancreatectomy, chronic hyperglycemia induces a loss of ␤ cell differentiation that could account for the marked alteration of glucoseinduced insulin secretion in this animal model of diabetes (7, 8) . Thus, the expression of several transcription factors involved in ␤ cell differentiation (transcription factor Pdx1, hepatocyte nuclear factors, etc.) and of a panel of genes involved in glucose recognition and stimulation of secretion (insulin, glucose transporter 2, mitochondrial glycerol-P dehydrogenase, etc.) was decreased in islets from hyperglycemic 90% pancreatectomized rats. Conversely, the expression of two genes weakly expressed in normal ␤ cells, hexokinase I and lactate dehydrogenase A (LDH-A), 1 was increased. This loss of ␤ cell differentiation was accompanied by an increase in ␤ cell size and in the islet mRNA levels of c-Myc, an early response gene that can up-regulate LDH-A expression (9) . The complete reversal of these changes by 2 weeks of blood glucose normalization with phlorizin strongly suggested that hyperglycemia per se was their triggering factor (7) .
c-Myc is a transcription factor of the basic helix-loop-helix leucine zipper (bHLH-LZ) family that heterodimerizes with Max, another bHLH-LZ protein. The binding of Myc-Max heterodimers to E boxes (canonical consensus sequence CACGTG) activates the transcription of multiple genes implicated in the regulation of cell metabolism, protein synthesis, cell division, and apoptosis (10) . c-Myc can also repress the expression of a number of genes and decrease cell differentiation by unclear mechanisms. On the other hand, Max binds to bHLH-LZ factors of the Mad family, and Mad/Max heterodimers can antagonize the effects of Myc/Max by a mechanism involving recruitment of histone deacetylase and prevention of gene transcriptional activation. Constitutive c-Myc expression because of gene activation is the cause of many human cancers, including lung carcinomas and Burkitt's lymphomas (10) . In differentiated cells, including fibroblasts, smooth muscle cells, and hepatocytes, c-Myc overexpression stimulates cell growth and proliferation, decreases cell differentiation, and sensitizes cells to apoptosis (11) (12) (13) (14) . Interestingly, these effects resemble those observed in ␤ cells chronically exposed to hyperglycemia (loss of differentiation, proliferation, and/or hypertrophy depending on the model, apoptosis), which suggests that an increase in c-Myc expression could play a role in the deleterious effects of chronic hyperglycemia on pancreatic ␤ cells. However, little is known about the regulation of c-Myc expression by glucose in pancreatic ␤ cells (15) . Therefore, we investigated whether and how glucose regulates ␤ cell c-Myc expression by measuring changes in the mRNA levels of c-Myc, Max, Mad1, and some of the putative Myc/Max target genes, ornithine decarboxylase (ODC), thymidine kinase (TK), LDH-A, and cyclindependent kinase 4 (CDK4) (10, 16, 17) . The study was carried out with both in vivo and in vitro models of hyperglycemia.
EXPERIMENTAL PROCEDURES
The effect of hyperglycemia on c-Myc expression was investigated in islets isolated from glucose-infused rats (in vivo hyperglycemia) and in islets or purified ␤ cells isolated from untreated rats and cultured at various glucose concentrations (in vitro hyperglycemia).
Islet Isolation-The rats were anesthetized by intraperitoneal injection of 100 mg⅐kg Ϫ1 pentobarbital (60 mg⅐ml Ϫ1 nembutal; Abbott Laboratories), and their pancreatic islets were isolated by collagenase digestion of the gland as described previously (7) . They were then separated from the digest by density gradient centrifugation using Histopaque 1077, microdissected, and hand picked under a stereomicroscope to ensure high purity of the preparation.
Glucose Infusions and Glucose Clamps-Male Harlan Sprague-Dawley rats (ϳ250 g) with indwelling jugular vein and carotid artery catheters were obtained from Taconic Farms (Germantown, NY). Following arrival at the animal facility, the rats were observed for at least 3 days to ensure general well being as assessed by weight gain and appearance. The rats were randomly assigned to a glucose-infused group (500 g⅐liter Ϫ1 hydrated glucose; McGaw, Irvine CA), a saline-infused group (4.5 g⅐liter Ϫ1 NaCl) or a noninfused, nonrestrained group (control). Infusions were performed in the carotid artery at a rate of 2 ml⅐h Ϫ1 for 24 h beginning at ϳ9:30 a.m. The infusion system consisted of a swivel and saddle (Lomir Biomedical Inc., Malone, NY) designed to allow the rat unrestricted mobility. Blood samples (ϳ0.1 ml) were drawn from the jugular vein at Ϫ1, Ϫ0.5 (prior to infusion), 0.1, 0.5, 1, 6, 12, and 24 h, placed in heparin-coated tubes, and immediately centrifuged. A portion of the supernatant (10 l) was immediately used for plasma glucose determination (Beckman Glucose Analyzer II; Beckman, Brea, CA), and the remainder (ϳ40 l) was stored at Ϫ20°C for later determination of plasma insulin concentration. The rats were allowed ad libitum food and water during infusion, and a standard light cycle (12 h of light, 12 h of dark) was maintained. At the end of the infusion period, the islets were isolated and processed for RT-PCR measurement of gene mRNA levels.
When in vivo hyperglycemia was extended up to 96 h, the rate of glucose infusion was regularly adjusted to keep plasma glucose close to 11 mmol⅐liter Ϫ1 . The rate of saline infusion was changed accordingly. At the end of the experiment, islets were isolated and processed for RT-PCR measurement of gene mRNA levels.
Islet Culture-The islets isolated from untreated male Wistar rats were cultured at 37°C in RPMI 1640 medium (Life Technologies, Inc.) containing 10 -30 mmol⅐liter Ϫ1 glucose, 5 g⅐liter Ϫ1 bovine serum albumin (BSA), 100 IU⅐ml Ϫ1 penicillin, and 100 g⅐ml Ϫ1 streptomycin in the presence of 5% CO 2 . In most cases, the islets from one pancreas (ϳ500 -1000) were precultured in 9 ml of RPMI-G10 medium for 1 week, during which the medium was renewed after 1 day and then every other day. Large islets (diameter, Ͼ200 m) with signs of central necrosis were discarded. After this week of preculture, the islets were cultured overnight (18 h ) in batches of 45-60 in 1.5 ml of RPMI medium containing 5-30 mmol⅐liter Ϫ1 glucose and various test substances. At the end of these 18 h of culture, a portion of the medium was withdrawn for insulin secretion measurement, and the islets were processed for RT-PCR measurement of gene mRNA levels.
c-Myc mRNA Half-life Determination-After 1 week of preculture in RPMI-G10 medium, the islets were cultured 18 h in the presence of G10 or G30. Each group was then divided in batches of 45-60 islets, further incubated for 0, 20, 40, 80, and 120 min in the same medium supplemented with 5 g/ml actinomycin D, and processed for RT-PCR measurement of gene mRNA levels.
Reaggregated Purified ␤ Cell Preparation and Culture-The islets isolated from untreated male Wistar rats were dissociated in single cells. The ␤ cells were purified by autofluorescence-activated cell sorting, reaggregated, and cultured for 3 days in Ham's F-10 medium (Life Technologies, Inc.) containing G10, 5 g⅐liter Ϫ1 BSA, 2 mmol⅐liter Ϫ1 glutamine, 50 mol⅐liter Ϫ1 isobutylmethylxanthine, and antibiotics as described (1) . Then, reaggregated ␤ cells were cultured overnight in a similar medium containing 10 -30 mmol⅐liter Ϫ1 glucose before their total RNA was extracted and processed for RT-PCR determination of gene mRNA levels.
RNA Extraction and cDNA Synthesis-Islet total RNA was extracted, quantified, and reverse transcribed into cDNA exactly as described (7), using Ultraspec (Biotecx Laboratories, Houston, TX) and the kit Superscript II (Life Technologies, Inc.). Control reactions lacking the reverse transcriptase were run in parallel.
Primers-Except for the measurements of c-Myc and LDH-A mRNA levels in islets from glucose-infused rats that were performed as described previously (7), pairs of primers were designed for multiplex polymerase chain reaction using Hybsimulator 4.0 software (Advanced Gene Computing Technologies, Irvine, CA). The sense and antisense primers were chosen in separate exons and their specificity was checked by BLAST search on the GenBank TM data base (Table I) . Semiquantitative Radioactive Multiplex PCR-Polymerization reactions were performed with a PerkinElmer 9700 Thermocycler in a 25-l reaction volume containing 1.5-3 l of cDNA (10 -20- (Table I) were chosen to be in the exponential phase of amplification of each product in control islet cDNA (Fig. 1) , as described previously (7). The thermal cycle profile was a 10-min denaturing step at 94°C to release DNA polymerase activity followed by the amplification cycles (1 min at 94°C, 1 min at the annealing temperature and 1 min at 72°C, unless otherwise specified in Table I ), and a final extension step of 10 min at 72°C. In each set, the gene products of interest were amplified with an internal control gene (TATA box-binding protein (TBP)) to correct for experimental variations between samples (TBP mRNA levels remained constant under the different experimental conditions). The amplimers were then separated on a 6% polyacrylamide gel in Tris borate EDTA buffer, in parallel with a 100-base pair DNA ladder. The gel was dried, and the amount of [␣-
32 P]dCTP incorporated in each amplimer was quantitated with a Cyclone Storage Phosphor System (Packard, Meriden, CT). The ratio of specific product/control gene was then calculated for each sample. Quintuplicate RT-PCR determination of the c-Myc/ TBP ratio from the same RNA preparation gave a within-assay coefficient of variation of 5.5%. The size of amplicons corresponded to the expected ones (published sequences), except for ODC that migrated at ϳ340 base pairs instead of 297 base pairs in PAGE. However, its size was correct in agarose gel electrophoresis, and its sequence (Eurogentec, Seraing, Belgium) corresponded to the published sequence of rat ODC (GenBank TM accession number J04792).
Western Blot-Equal batches of islets (ϳ500) were cultured 18 h under various conditions, washed three times with ice-cold phosphatebuffered saline, and precipitated with trichloroacetic acid (100 g⅐liter Ϫ1 ). After double ether extraction, the pellet was dried and solubilized in modified Laemmli buffer (0.5 g⅐liter Ϫ1 SDS, 1:10 (v/v) glycerol, 1:40 (v/v) ␤-mercaptoethanol, 62.5 mmol⅐liter Ϫ1 Tris, pH 6.8, and 50 mg⅐liter Ϫ1 bromphenol blue). Total islet proteins were then separated on a 10% SDS-PAGE and electrophoretically transferred to polyvinylidene difluoride membranes (PerkinElmer Life Sciences). After Ponceau S staining to check transfer efficiency, the membrane was blocked for 2 h at room temperature with 10% nonfat dry milk in Tris-buffered saline (pH 7.4) containing 0.05% Tween-20 (NFDM-TBST). It was then incubated overnight at 4°C in NFDM-TBST containing 2 g/ml anti-cMyc (N-262) polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA), washed with TBST, and incubated for 1 h at room temperature with horseradish peroxidase-conjugated anti-rabbit IgG antibody (0.1 g/ml NFDM-TBS). After six washes with TBST, detection of bound antibodies was carried out with the Supersignal West Femto kit (Pierce) using Kodak X-AR films.
Insulin Determinations-Insulin concentrations in the plasma and culture media were determined by radioimmunoassay using rat insulin as standard.
Data Analysis-The results are presented as the means Ϯ S.E. for the indicated number of animals or batches of islets. Statistical significance of differences between groups was assessed by unpaired Student's t test or by one-way analysis of variance (ANOVA) followed by a test of Newman-Keuls when more than two groups were compared. For mRNA half-life determination, mathematical analysis of the data was done using Prism 3.02 software (GraphPad Software, San Diego, CA).
RESULTS

Effect of Glucose Infusion and Glucose Clamp on Islet c-Myc
mRNA Levels-The effect of glucose on islet c-Myc mRNA levels was tested in an in vivo model of hyperglycemia associated with ␤ cell hypertrophy and impaired secretory function, the 50% glucose-infused rat (18, 19) . Rats were infused with 500 g⅐liter Ϫ1 glucose or 4.5 g⅐liter Ϫ1 NaCl solution at a flow rate of 2 ml/h for 24 h. During saline infusion, plasma glucose and insulin concentrations remained stable at ϳ5.5 mmol⅐liter
Ϫ1
and ϳ1 ng⅐ml Ϫ1 , respectively. In contrast, glucose infusion was followed by large increases in plasma glucose and insulin concentrations up to ϳ20 mmol⅐liter Ϫ1 and ϳ15 ng⅐ml Ϫ1 , respectively ( Fig. 2A) . Compared with control, noninfused or salineinfused rats, glucose-infused rats had an approximately 2-fold increase in islet c-Myc/TBP ratio without significant differences in Max1, Max2, and Mad1/TBP ratios (Table II) . An approximately 2-fold increase in the mRNA levels of two c-Myc target genes, ODC, and LDH-A was observed, but two other putative c-Myc target genes, TK and CDK4, remained unaffected by glucose infusion (Table II) .
When glucose was infused for 4 days at a constant flow rate, plasma glucose concentrations gradually returned to normal values, whereas a sustained increase in plasma insulin levels was observed (18) (not shown). At the end of that period, the islet c-Myc/TBP ratio was not different from that in control or saline-infused rat islets (n ϭ 2; not shown). In contrast, when plasma glucose was maintained elevated at ϳ11 mmol⅐liter Ϫ1 for 4 days by regularly adjusting the rate of glucose infusion (Fig. 2B) , islet c-Myc/TBP ratio was increased ϳ2fold compared with islets from matched saline-infused rats. There was a parallel rise in the ODC/TBP ratio but no change in Max1, Max2, Mad1, TK, or CDK4 mRNA levels (Table II) .
Changes in Islet c-Myc Expression Induced by Culture-The islets were cultured for 1 week in RPMI medium containing G10 or G30. Insulin secretion decreased by ϳ50% at both glucose concentrations over the first 3 days (p Ͻ 0.0001 for time effect by two-way ANOVA) but was consistently larger in the presence of G30 versus G10 (p Ͻ 0.0001 for glucose effect by two-way ANOVA), indicating good ␤ cell viability (Fig. 3A) .
The c-Myc/TBP mRNA ratio was low (0.7 Ϯ 0.2, n ϭ 4) in freshly isolated islets. After 18 h of culture in 10-30 mmol⅐liter Ϫ1 glucose, Table I ), and the products were separated on a 6% polyacrylamide gel. B, the logarithm of band intensities (quantified using a PhosphorImager) were plotted against the number of cycles. PCR for experimental samples were run at 28 cycles for c-Myc/TBP and 24 cycles for CDK4-ODC/TBP within the exponential phase of amplification of each product.
FIG. 2. Plasma glucose and insulin concentrations in glucoseinfused rats. Plasma glucose (top panel) and insulin (middle panel)
concentrations were measured in adult male rats infused with a solution containing NaCl 4.5 g⅐liter Ϫ1 (E, Saline) or glucose 500 g⅐liter Ϫ1 (q, Glucose). A, the flow rate was kept constant at 2 ml/h for 1 day. The results are the means for two saline-infused animals and the means Ϯ S.E. for five glucose-infused animals. B, the rate of glucose infusion (bottom panel) was regularly increased to keep plasma glucose at ϳ11 mmol⅐liter Ϫ1 for 4 days, and the rate of saline infusion was increased accordingly. The results are the means Ϯ S.E. for four to six animals. a glucose-dependent increase in c-Myc/TBP was observed, followed by a progressive and complete normalization after 1 week of culture (p Ͻ 0.05 for glucose effect and p Ͻ 0.01 for time effect by two-way ANOVA) (Fig. 3B) . The large increase in c-Myc mRNA levels induced by 18 h of culture in G30 was accompanied by an increase in c-Myc protein of the islets (Fig. 4) .
This early and transient rise in c-Myc/TBP ratio was also observed when islets were isolated without the use of Histopaque 1077 and was independent of the presence of fetal calf serum or BSA in the culture medium (not shown). In a single short term culture in the presence of G30, the rise was observed after 30 -60 min and became progressively larger during the next 18 h (not shown). Because this early rise could be due to the stress of islet isolation (20) , all subsequent experiments were performed after 1 week of preculture in the presence of G10.
Concentration-dependent Effect of Glucose on c-Myc mRNA Levels in Islets Precultured for 1 Week and Reaggregated
Purified Rat ␤ Cells-The islet c-Myc/TBP ratio was low in islets precultured in G10 for 1 week (0.48 Ϯ 0.07, n ϭ 5). It did not change after a further 18 h of culture when the glucose concentration remained at 10 mmol⅐liter Ϫ1 (0.52 Ϯ 0.09, n ϭ 13) but increased ϳ5-fold in the presence of G30 (2.51 Ϯ 0.36, n ϭ 13, p Ͻ 0.0001 by unpaired t test). In a subset of five experiments in which the intermediate glucose concentration of 20 mmol⅐liter Ϫ1 was also tested, a clear concentration-dependent effect of glucose on insulin release and islet c-Myc mRNA levels was observed (Fig. 5) . Under these conditions, c-Myc mRNA half-life was short and unaffected by glucose (35 Ϯ 4 and 25 Ϯ 1 min in the presence of G10 and G30 respectively, n ϭ 3, no significant difference by unpaired t test) (Fig. 6 ). Similar to in vivo hyperglycemic conditions, the glucose-dependent rise in the c-Myc/TBP mRNA ratio in vitro was accompanied by parallel changes in c-Myc target genes ODC and LDH-A/TBP mRNA ratios, without changes in Max, Mad1, TK, or CDK4 mRNA levels (Fig. 5) . To ascertain that the induction of c-Myc mRNA levels by high glucose occurred in ␤ cells within the islets, ␤ cells were purified, reaggregated, precultured for 3 days in the presence of G10, and further cultured 18 h in the presence of G10 or G30. Compared with ␤ cells kept in G10, the normalized c-Myc/TBP ratio increased from 1.0 Ϯ 0.06 to 1.81 Ϯ 0.18 in the presence of G30 (p Ͻ 0.01, n ϭ 4). 
Role of Cytosolic Calcium Rise in the Induction of Islet c-Myc Expression by High Glucose-When
of hyperglycemia on islet mRNA levels of c-Myc and c-Myc target genes
Adult male rats were infused with a solution containing NaCl 4.5 g ⅐ liter Ϫ1 (Saline) or glucose 500 g ⅐ liter Ϫ1 (Glucose) at a constant flow rate of 2 ml/h for 1 day (24-h glucose infusion; see Fig. 2A ) or clamped for 96 h at ϳ11 mmol ⅐ liter Ϫ1 plasma glucose (96-h glucose clamp; see Fig. 2B ). At the end of the experiment, the islets were isolated, their total RNA was extracted, and the gene/TBP mRNA ratios were measured by semiquantitative RT-PCR and expressed as percentages of the ratio measured in islets from noninfused control rats (24-h glucose infusion) or 96-h saline-infused rats (96-h glucose clamp). The results are the means Ϯ S.E. for the indicated number of animals. 3 . Time-dependent changes in c-Myc mRNA levels and insulin secretion in cultured rat islets. Batches of 40 -50 islets were cultured in RPMI medium supplemented with 5 g⅐liter Ϫ1 BSA in the presence of G10 or G30. A, the medium was renewed after 1 day and then every other day and saved for insulin secretion measurement. B, after 1, 3, and 7 days of culture, islet total RNA was extracted, and the c-Myc/TBP mRNA ratios were determined by multiplex RT-PCR and expressed relative to the ratio in freshly isolated islets from the same preparation. The results are the means Ϯ S.E. for three or four experiments. and the voltage-dependent Ca 2ϩ channel blocker nimodipine both inhibited insulin secretion in G10 and G30 and markedly reduced c-Myc and ODC mRNA levels in G30 (Fig. 7A) . In contrast, stimulation of Ca 2ϩ entry by high potassium-induced membrane depolarization in the presence of diazoxide to prevent any effect of glucose on ␤ cell membrane potential (21) reproduced the effect of G30 on insulin secretion and islet c-Myc and ODC mRNA levels (Fig. 7B) . Again, these effects were completely abolished by nimodipine, confirming their Ca 2ϩ dependence. The effect of G30 on islet c-Myc expression was not mediated by insulin released in the culture medium, because islet c-Myc/TBP ratio and its induction by G30 remained unaffected by the addition of 1 mol⅐liter Ϫ1 exogenous insulin to the culture medium (not shown).
Effect of Clonidine and cAMP on Islet c-Myc Expression-
The inhibition of insulin secretion by ␣ 2 -adrenoreceptor agonists results from several mechanisms: a partial repolarization of the ␤ cell membrane with a small decrease in [Ca 2ϩ ] i (22, 23) , a strong inhibition of adenylate cyclase (24) , and a major distal inhibition on Ca 2ϩ -induced exocytosis (22, 23) . After 18 h of culture in the presence of 1 mol⅐liter Ϫ1 clonidine, insulin secretion was inhibited by ϳ85% in G10, G30, and G10/K30/Dz (Fig. 8B) . Under these conditions, the c-Myc/TBP mRNA ratio was unaffected in G10, slightly reduced in G30, and unaffected in G10/K30/Dz (Fig. 8A) . These effects of clonidine cannot be ascribed to changes in [Ca 2ϩ ] i , because [Ca 2ϩ ] i measured after overnight culture in G30 or G10/K30/Dz was unaffected by addition of clonidine during culture (data not shown). The membrane-permeable agent dibutyryl-cAMP markedly stimulated insulin secretion and c-Myc mRNA levels in G10 and G10/K30/Dz but was ineffective in G30 (Fig. 8) . Under these conditions, clonidine partially inhibited insulin secretion but did not affect c-Myc mRNA levels. An increase in c-Myc protein level was observed in islets stimulated for 18 h with dibutyrylcAMP in G10/K30/Dz medium versus G10 alone (Fig. 9) . Ϫ1 BSA in the presence of G10. Batches of 40 -60 islets were then cultured overnight (18 h) in the presence of G10, G20, or G30. At the end of culture, insulin secretion was measured, islet total RNA was extracted, and the gene/ TBP mRNA ratios were determined by RT-PCR and expressed relative to the ratio in islets cultured in G10. Shown are representative PCR results for c-Myc, Max-Mad, ODC-CDK4, LDH-A, and TK on the left and the means Ϯ S.E. for five experiments on the right. The light upper band in Max product corresponds to Max1, whereas the strong band corresponds to Max2, the predominant isoform in rat islets.
FIG. 6. Effect of glucose on c-Myc mRNA half-life.
A, after 1 week of preculture in G10, islets were cultured 18 h in the presence of G10 or G30. Batches of 40 -60 islets were then cultured in the same medium supplemented with 5 g⅐ml Ϫ1 actinomycin D for the time indicated. Their total RNA was extracted, and c-Myc, TBP, and cyclophilin mRNA levels were determined by RT-PCR. At time 0, c-Myc/TBP mRNA ratio was increased 5.7 Ϯ 1.9-fold in G30 versus G10 (n ϭ 3). B, band intensities were expressed as percentages of the maximal intensity, and, except for cyclophilin, which did not decrease within 2 h, the data were fitted to a one-phase exponential decay equation (Y ϭ Span * e (ϪK*X) ϩ Plateau , where Span and plateau are fixed at 100 and 0%, respectively, and half-life ϭ 0.69/K). The data are the means Ϯ S.E. for three experiments. ] i -decreasing agents on insulin release and islet c-Myc expression. After preculture for 1 week in G10, batches of 40 -60 islets were cultured 18 h in the presence of G10 or G30 and various test substances. At the end of culture, insulin secretion was measured, and islet total RNA was extracted. The c-Myc/TBP and ODC/TBP mRNA ratios are expressed relative to the ratio measured in islets cultured in G10 alone. Test substances were: 50 mol⅐liter Ϫ1 diazoxide (Dz), 1 mol⅐liter Ϫ1 nimodipine (Nimo), ϩ 27.4 mmol⅐liter Ϫ1 NaCl (Osmotic control), ϩ 27.4 mmol⅐liter Ϫ1 KCl ϩ 100 mol⅐liter Ϫ1 diazoxide (K30Dz). The results are the means Ϯ S.E. for four experiments. *, significant effect of G30, p Ͻ 0.05 or less; #, significant effect of test substance at the same glucose concentration, p Ͻ 0.05 or less; §, significant effect of test substance versus K30/Dz, p Ͻ 0.01 or less.
tending previous observations of a rise in c-Myc mRNA levels in glucose-starved insulin-secreting RIN cells restimulated with glucose (15) and in islets from hyperglycemic 90% pancreatectomized rats (7) . Thus, high glucose increased c-Myc mRNA levels in rat islets in vivo for up to 4 days and in islets and purified pancreatic ␤ cells in vitro. This increase is attributed to a higher transcription of c-myc gene, because c-Myc mRNA degradation was unaffected by glucose. It was accompanied by a rise in c-Myc protein and a parallel increase in the mRNA levels of two well characterized c-Myc target genes, ODC and LDH-A, both in vivo and in vitro. Consistent with these results, both ODC and LDH-A mRNA levels were found to increase in glucose-stimulated MIN6 cells (25) , and a parallel increase in LDH-A and c-Myc mRNA levels was observed in islets from hyperglycemic 90% pancreatectomized rats (ODC was not tested in that study) (7) . Two other putative c-Myc target genes involved in cell proliferation, TK and CDK4, were not affected by hyperglycemia. The fact that the mRNA levels of only two of four putative c-Myc target genes increased in parallel to c-Myc mRNA is not so surprising, because the list of putative c-Myc target genes largely depends on the methodology used, the cell type, and its degree of differentiation or transformation (10, 13) .
It could be argued that G10 is not a basal condition to test the effect of high glucose on gene expression and that a lower glucose concentration should have been used in vitro. However, culturing islets at 5 mmol⅐liter Ϫ1 glucose (G5) is associated with a large increase in ␤ cell apoptosis (5, 26) , a condition under which c-Myc mRNA levels are also increased (27) . The mechanisms leading to this rise have been characterized and will be presented in another paper; they are clearly independent of changes in [Ca 2ϩ ] i or cAMP levels and are apparently related to the low rate of glucose metabolism. 2 It is also important to note that fasting for up to 3 days was not accompanied by an increase in islet c-Myc mRNA levels, suggesting that the rise induced by culture at low glucose (G5) is specific to the in vitro situation (27) . Because our in vitro model of hyperglycemia was developed to investigate the possible mechanisms by which hyperglycemia stimulates ␤ cell c-Myc expression in vivo, it was important to choose as a reference the concentration of glucose that gave the minimal level of c-Myc expression in vitro. In this context, we would like to emphasize that the inverted bell-shaped effect of glucose concentration on islet c-Myc mRNA levels in vitro could lead to the erroneous conclusion that glucose does not affect c-Myc expression if only tested at 5 and 20 -30 mmol⅐liter Ϫ1 glucose (27 ] i results from the stimulation of insulin secretion and accumulation of ␤ cell secretory products in the culture medium for two reasons. First, the addition of a saturating concentration of exogenous insulin was without effect on islet c-Myc expression at both G10 and G30. Second, the large inhibition of insulin secretion produced by clonidine in the presence of high glucose or high potassium was not accompanied by a parallel reduction in c-Myc mRNA levels. The small inhibitory effect of clonidine on the stimulation of c-Myc expression by high glucose probably results from an inhibition of adenylate cyclase and reduction in islet cAMP (24) effect of glucose was partly mediated by Ca 2ϩ activation of adenylate cyclase (29) , but this hypothesis is not supported by the synergistic effect of high potassium and dibutyryl-cAMP on islet c-Myc expression. It is, however, clear that like other early response genes in insulin-secreting cell lines, islet c-Myc expression is Ca 2ϩ -and cAMP-regulated. The major difference resides in the fact that islet c-Myc expression lasted much longer than what has been reported for egr-1, c-fos, or nur77 induction (30 -32) .
Potential Role of c-Myc in Pancreatic ␤ Cells under Physiological and Pathological Conditions-We recently suggested that the increase in c-Myc expression observed in islets from hyperglycemic 90% pancreatectomized rats could be the cause of ␤ cell hypertrophy, loss of differentiation, and loss of function occurring in that model of diabetes (6, 7) . The present study sets the basis of that hypothesis by demonstrating the stimulatory effect of high glucose on islet c-Myc expression and by partially identifying the mechanisms involved in that effect. It is also tempting to speculate that c-Myc expression could be involved in the regulation of ␤ cell growth by glucose and cAMP-raising agents (33) . Preliminary data about the effect of c-Myc overexpression in mouse pancreatic ␤ cells (11, 34) and the actual view of c-Myc function in the control of cell growth, differentiation, and apoptosis (10) are in favor of our hypothesis.
Conclusion-The expression of c-Myc in rat pancreatic ␤ cells is stimulated by high glucose in a Ca 2ϩ -dependent manner and by cAMP. Because c-Myc overexpression has pleiotropic effects on cells (stimulation of growth (hypertrophy/proliferation), sensitization to apoptosis, and decrease of cell differentiation), this effect of glucose could be relevant to ␤ cell mass adaptation to substrate supply under physiological conditions and to ␤ cell loss of differentiation and altered secretory function in states of chronic hyperglycemia.
